| # | Title | Journal | Year | Citations |
|---|
| 1 | Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease | New England Journal of Medicine | 2017 | 1,738 |
| 2 | Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. | Heart | 1993 | 981 |
| 3 | Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy | European Journal of Heart Failure | 2010 | 787 |
| 4 | SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review | Diabetologia | 2018 | 641 |
| 5 | Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial | Lancet Diabetes and Endocrinology,the | 2015 | 535 |
| 6 | Relationship Between Coronary Artery Remodeling and Plaque Vulnerability | Circulation | 2002 | 514 |
| 7 | Vascular dysfunction—The disregarded partner of Alzheimer's disease | Alzheimer's and Dementia | 2019 | 454 |
| 8 | Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease | Science | 2016 | 438 |
| 9 | Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology | European Journal of Heart Failure | 2018 | 434 |
| 10 | Self‐care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology | European Journal of Heart Failure | 2011 | 318 |
| 11 | Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations | Clinical Science | 2008 | 247 |
| 12 | Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial | Lancet, The | 2016 | 229 |
| 13 | Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction | Circulation: Heart Failure | 2011 | 219 |
| 14 | Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. | Heart | 1988 | 217 |
| 15 | Activation of Nrf2 in Endothelial Cells Protects Arteries From Exhibiting a Proinflammatory State | Arteriosclerosis, Thrombosis, and Vascular Biology | 2009 | 216 |
| 16 | Effect of Mivazerol on Perioperative Cardiac Complications during Non-cardiac Surgery in Patients with Coronary Heart Disease | Anesthesiology | 1999 | 214 |
| 17 | Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease | Journal of the American College of Cardiology | 2017 | 214 |
| 18 | The ACE gene and muscle performance | Nature | 2000 | 208 |
| 19 | European Society of Cardiology Heart Failure Association Standards for delivering heart failure care | European Journal of Heart Failure | 2011 | 197 |
| 20 | Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure | Journal of the American College of Cardiology | 2016 | 191 |
| 21 | Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document | European Journal of Heart Failure | 2013 | 182 |
| 22 | Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review | European Journal of Heart Failure | 2017 | 181 |
| 23 | Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial | European Journal of Heart Failure | 2016 | 173 |
| 24 | Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial | Nephrology Dialysis Transplantation | 2020 | 168 |
| 25 | Delayed recovery of coronary resistive vessel function after coronary angioplasty | Journal of the American College of Cardiology | 1993 | 165 |
| 26 | Zebrafish as model organisms for studying drug‐induced liver injury | British Journal of Clinical Pharmacology | 2014 | 150 |
| 27 | Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study | BMC Medicine | 2020 | 148 |
| 28 | Computational techniques for ECG analysis and interpretation in light of their contribution to medical advances | Journal of the Royal Society Interface | 2018 | 143 |
| 29 | Heart muscle disease related to HIV infection: prognostic implications | BMJ: British Medical Journal | 1994 | 141 |
| 30 | Anatomic features in victims of sudden coronary death. Coronary artery pathology | Circulation | 1992 | 141 |
| 31 | Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome | Critical Care Medicine | 1996 | 137 |
| 32 | The Metabolodiuretic Promise of Sodium-Dependent Glucose Cotransporter 2 Inhibition | JAMA Cardiology | 2017 | 135 |
| 33 | European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure | European Journal of Heart Failure | 2020 | 131 |
| 34 | Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study | BMJ, The | 2013 | 127 |
| 35 | Associations Between Dietary Fiber and Inflammation, Hepatic Function, and Risk of Type 2 Diabetes in Older Men | Diabetes Care | 2009 | 115 |
| 36 | Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults | Hypertension | 2019 | 110 |
| 37 | Atherosclerosis: what is it and why does it occur? | Heart | 1993 | 104 |
| 38 | The contribution of thrombosis to the clinical expression of coronary atherosclerosis | Thrombosis Research | 1996 | 103 |
| 39 | The Sarcomeric Z-Disc and Z-Discopathies | Journal of Biomedicine and Biotechnology | 2011 | 100 |
| 40 | Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology | European Journal of Heart Failure | 2020 | 100 |
| 41 | Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction | JACC: Heart Failure | 2020 | 100 |
| 42 | Increased Risk of All-Cause Mortality and Renal Graft Loss in Stable Renal Transplant Recipients With Hyperparathyroidism | Transplantation | 2015 | 98 |
| 43 | Acute coronary thrombosis--the role of plaque disruption and its initiation and prevention | European Heart Journal | 1995 | 94 |
| 44 | Genome-wide association study of MRI markers of cerebral small vessel disease in 42,310 participants | Nature Communications | 2020 | 93 |
| 45 | 18 F-Fluoride Signal Amplification Identifies Microcalcifications Associated With Atherosclerotic Plaque Instability in Positron Emission Tomography/Computed Tomography Images | Circulation: Cardiovascular Imaging | 2019 | 92 |
| 46 | Primary restrictive cardiomyopathy: Clinical and pathologic characteristics | Journal of the American College of Cardiology | 1991 | 91 |
| 47 | Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF | European Journal of Heart Failure | 2020 | 91 |
| 48 | Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction | European Journal of Heart Failure | 2021 | 88 |
| 49 | In Vitro and In Vivo Cardiomyogenic Differentiation of Amniotic Fluid Stem Cells | Stem Cell Reviews and Reports | 2011 | 82 |
| 50 | Detection of Pathological Tachycardia by Analysis of Electrogram Morphology | PACE - Pacing and Clinical Electrophysiology | 1986 | 81 |
